Literature DB >> 2550357

Chronic neurological toxicity associated with exposure to volatile substances.

Y Lolin1.   

Abstract

1. The main neurological disorders associated with chronic VSA are peripheral neuropathy, cerebellar disease, chronic encephalopathy and dementia. Apart from peripheral neuropathy, the clinical features are non-specific, evidence for solvent-related toxicity is in most cases circumstantial and there is no clear dose/response relationship. 2. Peripheral neuropathy is mainly associated with n-hexane and methyl n-butyl ketone. 3. Cerebellar disease is usually associated with toluene exposure; in the more severe cases there is often radiological evidence of irreversible cerebellar atrophy. 4. Chronic encephalopathy and dementia are the most serious consequence of solvent exposure, particularly to toluene in abusers and to mixed solvents in industrial workers. Postmortem studies in some abusers have shown generalized axonal degeneration, demyelination and brain atrophy. 5. Further studies on low level solvent exposure are needed as little is known about the neurological consequences of mild VSA, especially as regards individual susceptibility and possible interactions between solvents and other toxins such as ethanol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550357     DOI: 10.1177/096032718900800407

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  10 in total

Review 1.  Solvent abuse.

Authors:  C H Ashton
Journal:  BMJ       Date:  1990-01-20

Review 2.  Inhalant abuse among adolescents: neurobiological considerations.

Authors:  D I Lubman; M Yücel; A J Lawrence
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

3.  Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in Ciudad Juarez, Mexico.

Authors:  Meghan D Morris; Patricia Case; Angela M Robertson; Remedios Lozada; Alicia Vera; John D Clapp; Maria Elena Medina-Mora; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2011-03-26       Impact factor: 4.492

Review 4.  An introduction to the clinical toxicology of volatile substances.

Authors:  R J Flanagan; M Ruprah; T J Meredith; J D Ramsey
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 5.  Volatile substance abuse.

Authors:  G P Marelich
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 10.817

Review 6.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

7.  Recanting of life-time inhalant use: how big a problem and what to make of it.

Authors:  Steven C Martino; Daniel F McCaffrey; David J Klein; Phyllis L Ellickson
Journal:  Addiction       Date:  2009-05-12       Impact factor: 6.526

8.  Inhaled Solvent Abuse Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Authors:  Salini Thulasirajah; Jean Michaud; Asif Doja; Hugh J McMillan
Journal:  Child Neurol Open       Date:  2020-06-19

9.  Effects of volatile substance abuse on the respiratory system in adolescents.

Authors:  Halime Sc Büker; Esen Demir; Zeki Yüncü; Figen Gülen; Levent Midyat; Remziye Tanaç
Journal:  Multidiscip Respir Med       Date:  2011-06-30

10.  Coal tar creosote abuse by vapour inhalation presenting with renal impairment and neurotoxicity: a case report.

Authors:  Thomas F Hiemstra; Christopher Oc Bellamy; Jeremy H Hughes
Journal:  J Med Case Rep       Date:  2007-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.